Navigation Links
Rutgers research partner Stemcyte, Inc., expands to New Jersey
Date:5/1/2008

NEW BRUNSWICK, N.J. Officials from Rutgers University and state government today welcomed StemCyte, Inc., to the Garden State. One of the factors in the companys decision to move into New Jersey was a desire to be closer to Rutgers and the groundbreaking research taking place at the university.

StemCytes new office in Ewing Township will house members of its executive management and therapeutics team, establishing a base of operations for the companys northeast United States therapeutics program. StemCyte is a global umbilical cord blood (UCB) stem cell and therapeutic products company.

Rutgers and StemCyte have been collaborating on a spinal cord injury therapy in development by Dr. Wise Young, the Richard H. Shindell Professor of Neuroscience. Youngs therapy, which uses StemCytes proprietary human UCB stem cells in conjunction with lithium, is undergoing clinical trials in China in a network of medical facilities brought together by Young.

I am proud of New Jersey's and Rutger's commitment to stem cell therapeutics, Young said. StemCyte is the only company today that is actually curing hundreds of people with stem cells. Over the past six years, StemCyte has treated patients with 35 types of diseases in 32 countries with a UCB stem cell product.

The synergy emanating from this partnership of academia and industry is already global in its scope, said Richard L. McCormick, president of Rutgers, The State University of New Jersey. Dr. Youngs work with people in China offers new hope to spinal cord injury patients and their families here in New Jersey and worldwide. We are pleased to welcome StemCyte as new neighbors in a statewide community that is focused on medical progress.

To further encourage this industrial-academic research and development partnership, the New Jersey Economic Development Authority is supporting StemCytes move with a 10-year Business Employment Incentive Program (BEIP) grant that will facilita
'/>"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. The Zonta Club of Essex County honors Rutgers College of Nursings Rachel Jones
2. Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing
3. Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development
4. NJSNA honors Rutgers College of Nursings Linda Flynn for excellence in research
5. Rutgers center sparks liquid bandage, a new frontline wound treatment
6. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
7. Rutgers College of Nursing emerita professor Beverly Whipple receives FSSS book award
8. N.J. nurses are overworked according to Rutgers College of Nursing professor
9. Rutgers biomaterial debuts in clinical trials of new stent
10. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
11. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...BEND, Ind., Jan. 8 Press Ganey Ass...ientFlow Technology (PatientFlow), a,leading prov... for hospitals.,The Boston-based company speciali...strategic solutions for patient flow issues such a...umped or delayed surgeries, and lack of,available...
(Date:1/7/2009)...CH, Fla., Jan. 7 Non-profits Medical Tourism Asso...Monterrey Health Care City ( www.monterreyciudad...te the 1st Latin America Medical Tourism and Healt...09 in Monterrey, Mexico at the Intercontinental Pr...stinations of medical tourism in Latin America, ha...
(Date:1/7/2009)...., Jan. 7 Insulet Corporation (Nasdaq: PODD ), ...od(R) Insulin Management System, today announced t.... Morgan Healthcare Conference. Management is sche...0 a.m. PST on January 14, 2009 at The Westin St. F...rence presentation, material information concernin...
(Date:1/7/2009)..., Tenn., Jan. 7 Ambulatory Services of America,In...a, LLC, its seventh,radiation oncology joint ventu...g Gulf Coast Cancer Center - Gulf Shores, P.C., Mo...abama Radiation Oncology, P.C., and ASA,s,subsidia...ROSA of South,Alabama will own and operate four ra...
Breaking Medicine News(10 mins):Health News:Press Ganey Acquires PatientFlow Technology 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 2Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 3Health News:The Non-Profits Medical Tourism Association (MTA), Monterrey Health Care City (MHCC) Have Partnered Together to Create the 1st Latin America Medical Tourism and Health Tourism Congress Which Occurs April 27-29th, 2009 in Monterrey, Mexico at the Intercont 4Health News:Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers 2
...sts at the University of Canberra claim that they ...viour of children. // Positive parenting program w... master unit, with an intention to make parenting ... anxiety levels in parents by altering children’s ...
...tending the 16th International AIDS Conference in ...ica are at risk of plunging into a silent epidemic...Middle East and North Africa carry the virus that ...s the lowest rate of HIV infection in the world ac...
...nsplant at TG Hospital gave a B.C. youngster a bow...rince George, B.C. was told to prepare// for the d...o prepare and to accept, but I still wasn't on tha...recovering following a high-risk, four-organ trans...
...o improve the management of the Queensland's healt... has called for a doctor to head the system//. Dr ... that Dr Bruce Flegg, the new Liberal leader, coul...iling system and added that Peter Beattie Governme...
Other Medicine News:Health News:Parenting skills to manage bad behaviour 2Health News:Risk of Silent AIDS epidemic in Middle East and North Africa 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 2Health News:Rare Transplant Gives B.C Youngster 4 New Organs 3
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
(Date:12/30/2008)...wswire/ -- The Coalition for 21st Century Medicine...nentech, Inc. on December 5, 2008, seeking to rest...ic tests to physicians and patients. The request ...rm patient care and rests on flawed scientific and... to encourage the research, development, and comme...
(Date:12/27/2008)...lence, offers to ease cloning costs for Clonaid cl...27 Six years to the day...ld, Dr. Brigitte Boisselier, head of the company t...babies cloned by her company are growing up health...lies, privacy. , , "We,ve helped almost 100 fam...
(Date:12/17/2008)...-- PEAK Surgical, Inc., a medical,device company ...based on a,proprietary technology, announced toda...) has granted the company 510(k) clearance to mark...gulation of soft tissue during,plastic and recons...,orthopedic, arthroscopic, spinal and neurologica...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4New Method Better Predictor of In Vitro Fertilization Success 23077 1New Method Better Predictor of In Vitro Fertilization Success 23077 2Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Penn animal study identifies new DNA weapon against avian flu 23073 1Penn animal study identifies new DNA weapon against avian flu 23073 2Penn animal study identifies new DNA weapon against avian flu 23073 3Fungi the cause of many outbreaks of disease but mostly ignored 3851 1Fungi the cause of many outbreaks of disease but mostly ignored 3851 2Fungi the cause of many outbreaks of disease but mostly ignored 3851 3
...cience Closer to Targeted, Improved Therapies , BE...y the,National Institute on Drug Abuse (NIDA), par...he first time identified genes that,might increase...reakthrough research was conducted by Dr. George U...m led by Dr. Jed Rose at the,Center for Nicotine a...
...ril 02, 2007 /PRNewswire/ -- Berlex, Inc., a U.S.,...nounced today the,results of a retrospective study...ntibodies (NAbs) that can develop in response to,B...redict clinical,response in patients with multiple...over 6,600 patients across three continents. It,is...
Other Medicine Technology:NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 2NIDA Study Identifies Genes That Might Help Some People Abstain,from Smoking 3Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 2Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 3Large Study Shows that Presence of Neutralizing Antibodies Did Not,Predict Clinical Response to Betaseron Treatment 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: